Androski Lindsay's Form 4 filing
Arbutus Biopharma Corp (ABUS) · filed Sep 23, 2026
- Accession no.
- 0001447028-26-000053
- Filed
- Sep 23, 2026, 8:32 PM ET
- Trade date
- Sep 18, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Androski LindsayCIK 0001936604 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Shares | MOption exerciseAcquired | +116,408 | $3.20 | +$372,505.6 | 144,408 | Direct | |
| Sep 18, 2026 | Common Shares | MOption exerciseAcquired | +10,456 | $4.39 | +$45,901.84 | 154,864 | Direct | |
| Sep 18, 2026 | Common Shares | FTax withholdingDisposed | −82,527 | $5.07 | −$418,411.89 | 72,337 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Shares | MOption exerciseDisposed | −116,408 | $0.00 | $0 | 194,014 | Direct | |
| Sep 18, 2026 | Common Shares | MOption exerciseDisposed | −10,456 | $0.00 | $0 | 61,244 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.